Regeneron Tarrytown
power station with capacity >1MW in Westchester County, New York
Positive
Negative
Entity sentiment
Reports
News
Opinions
Statements
Articles
Relations
science Apr 23, 2026, 10:47 PM
Regeneron's gene therapy offers hope for children with hearing loss - The FDA approved Regeneron's Otarmeni as the first gene therapy for genetic hearing loss.
- This therapy aims to treat a rare form of hearing loss linked to the OTOF gene mutation affecting about 50 babies annually in the U.S.
- The approval signifies a critical advancement for families facing genetic hearing loss, providing a permanent solution compared to cochlear implants.
100
2026 All rights reserved
2026 All rights reserved